Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01BGK
|
|||
Former ID |
DNC014022
|
|||
Drug Name |
1-(4-methoxyoxazol-2-yl)-7-phenylheptan-1-one
|
|||
Synonyms |
CHEMBL526161; 1-(4-methoxyoxazol-2-yl)-7-phenylheptan-1-one; SCHEMBL2163269
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H21NO3
|
|||
Canonical SMILES |
COC1=COC(=N1)C(=O)CCCCCCC2=CC=CC=C2
|
|||
InChI |
1S/C17H21NO3/c1-20-16-13-21-17(18-16)15(19)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3
|
|||
InChIKey |
PLTPISAOEFIJFK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hyd... Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.